Published reports have indicated
additional disease in which dietary elements may play a role in pathogenesis.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for
additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with
additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of
diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow
additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our
additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Last weekend, Scott sharply criticized the federal government and lawmakers for dragging their feet
in providing resources needed to combat the
disease, including 10,000 Zika preparedness kits, mosquito spray and
additional manpower to root out the mosquitoes.
The Xarelto partnership is seeking
additional approved uses, with trials underway
in patients with acute coronary syndrome, and for reduction of major adverse cardiovascular events
in patients with heart failure or peripheral artery
disease.
Amicus Therapeutics, Inc. (NASDAQ: FOLD) announced the path forward for U.S. regulatory approval for migalastat, including an
additional trial
in Fabry
disease, focused on gastrointestinal (GI) symptoms.
Micro greens are considered to be
in the group of what are newly referred to as «functional foods» which are food products that contain particular health promoting or
disease preventing properties that are
additional to their normal nutritional values.
After completing this training if you are interested
in further information regarding concussions, visit the
additional resources link to find handy printouts, related articles and supplementary concussion websites such as STOP Sports Injuries and the Centers for
Disease Control and Prevention's Head's Up: Concussion
in Youth Sports.
After completing this training if you are interested
in further information regarding abuse protection, visit the
additional resources link to find handy printouts, related articles and access to supplementary abuse websites such as the National Center for Missing & Exploited Kids, Child Help, Centers for
Disease Control: Child Maltreatment Prevention and Darkness to Light.
An estimated 12 million people
in the United States have food allergies, and an
additional 2 million have celiac
disease, a disorder
in which the body's immune system attacks itself when exposed to gluten, a protein found
in wheat, barley and rye.
If there are
additional symptoms such as vomiting, diarrhea and / or blood
in the child's stools, the child may have a chronic intestinal illness such as Crohn's
disease, ulcerative colitis, or celiac
disease.
In fact, the celiac positive kids were breastfed on average for 1.4
additional months compared to those negative for the
disease.
Of this number, 2.5 million Americans are living with celiac
disease but are undiagnosed, putting them
in danger of
additional long - term health conditions should the
disease not be properly diagnosed.
Additional shots are also needed
in some cases to offer full immunity to specific
diseases (3).
Additional human studies are needed to explore how individual differences
in maternal breast milk composition could predispose to intestinal inflammatory conditions, such as allergic
disease.
Additional challenges include lasting disparities
in smoking rates and chronic
disease outcomes, rising STD rates, and persistent elevated rates of tick - borne illnesses compared with the rest of upstate New York.
The Senate minority leader appeared Wednesday on Long Island and
in Rockland County to urge the Centers for
Disease Control to unlock millions
in additional funding included
in the recently passed federal budget.
Legislation passed
in the wake of that outbreak requires building owners to register their cooling towers with the city, and City Council Speaker Melissa Mark - Viverito said members would now see if there are any
additional steps they can take to help guard against future cases of Legionnaires»
disease.
«Loose animals can create
additional risks of injury and
disease to people
in the affected area.»
Jaenisch says that the method that identified the single point mutation
in SNCA's enhancer could be used to pinpoint
additional pathogenic genes for sporadic PD and sift through the GWAS hits for other
diseases, including Alzheimer's
disease, cancer, diabetes, and multiple sclerosis.
Research
in Parkinson's and Huntington's has uncovered
additional examples of
disease proteins that, when mutated, stymie protein clearance pathways
in neurons.
Londoners of the 17th century watched
additional waves of
disease come
in by ship from Holland.
Our data demonstrate the feasibility of targeted gene disruption
in multiple rat strains within 4 months time, paving the way to a humanized monoclonal antibody platform and
additional human
disease models.
Additional analysis of UK Biobank data from 112,338 people of European ancestry revealed that a specific form of rs9349379 known as the G allele, which was present
in 36 % of these individuals, was associated with an increased risk of coronary artery
disease.
Disease or an injury to the retina also can cause the loss of protective proteins
in the cells, resulting
in additional cell death.
There was also less than one
additional case for every 1,000 women per year for heart
disease and for stroke
in the hormone - treated women compared with those on placebo.
The task also revealed an
additional memory impairment unique to those with very mild Alzheimer's
disease, indicating the changes
in cognition that result from Alzheimer's are qualitatively different than healthy aging.
For example,
in the combined hormone therapy trial, treated 50 - to 59 - year - olds had five
additional cases of heart
disease and five more strokes per 10,000 women annually compared with the same - aged group on placebo.
They said the key messages from the study were that stroke is a highly preventable
disease globally, regardless of age and sex; that the relative importance of modifiable risk factors means there should be development of regional or ethnic - specific primary prevention programs, and that
additional research on stroke risk factors is needed for countries and ethnic groups not included
in INTERSTROKE.
To compute how
additional pollution from ships increases risk of
disease for exposed populations, especially those living
in coastal communities or along major shipping lanes and far inland
in some nations like India, the team incorporated important underlying health information from the World Health Organization and Global Asthma Network.
Although nanobacteria may not cause kidney stone
disease, Coe notes
additional circumstantial evidence: At least four teams have reported tiny spherical deposits
in the calcified plaques that often appear
in the kidneys of patients who suffer from kidney stones.
«While many patients with Anti-NMDAR Encephalitis present with isolated psychiatric symptoms, most of these patients subsequently develop,
in a matter of days,
additional neurological symptoms which help to make the diagnosis of the
disease.
A study by investigators at Brigham and Women's Hospital (BWH) published this week
in PLOS ONE identifies four factors that may account for sex differences
in statin therapy among patients with coronary artery
disease (CAD), pointing to interventions and
additional research that will be needed to help overcome this sex disparity and reduce cardiovascular risk for women.
Because environmental exposures have not had time to impact IBD progression
in children, researchers have a clearer genetic picture of the
disease allowing them to pick out
additional genes overlooked
in adult research, says senior study author Hakon Hakonarson, director of the Center for Applied Genomics at The Children's Hospital of Philadelphia.
«While it is very well accepted that improving cardiovascular health can reduce the risk of stroke and heart attacks, we now believe that drugs aimed at improving cerebrovascular health may be an
additional strategy to treating brain
diseases in the future.»
Eight
additional affected children
in six unrelated families were found to also have
disease - causing mutations
in this gene.
In an extended analysis, the team identified an additional 33 genetic regions that are also involved in several common immune - mediated conditions (celiac disease, Crohn's disease, ulcerative colitis, type 1 diabetes, rheumatoid arthritis, sarcoidosis and psoriasis
In an extended analysis, the team identified an
additional 33 genetic regions that are also involved
in several common immune - mediated conditions (celiac disease, Crohn's disease, ulcerative colitis, type 1 diabetes, rheumatoid arthritis, sarcoidosis and psoriasis
in several common immune - mediated conditions (celiac
disease, Crohn's
disease, ulcerative colitis, type 1 diabetes, rheumatoid arthritis, sarcoidosis and psoriasis).
Neurogeneticist Ivan Rodriguez of the University of Geneva
in Switzerland and colleagues wondered whether there might be
additional such receptors that respond to a
disease «scent,» perhaps by detecting chemicals associated with bacteria and inflammation.
«We introduce a new definition of global health financing — one that includes
additional public R&D spending for neglected
diseases,» said lead author Marco Schäferhoff, PhD, of SEEK Development
in Berlin, Germany.
Additional studies
in other adult populations would further advance understanding of the diet's influence on heart
disease risk.
Whilst established to examine possible safety issues with biologic therapies, it provides the opportunity to look at
additional benefits beyond the direct effect on
disease severity,» explains William Dixon, MD, MRC clinician scientist / senior clinical lecturer and honorary consultant rheumatologist; Arthritis Research UK Epidemiology Unit, The University of Manchester; and an investigator
in the study.
The report suggests that patients may benefit from
additional assurances from clinical staff regarding; success rates
in halting
disease progression with anti-VEGF therapy, how it can reduce the risk of becoming blind
in the future, and the low likelihood of serious problems occurring following the injections.
Additional experiments using a combination of maraviroc and a drug that blocks the VEGF protein suggest that the treatment duo could be an effective way to prevent metastatic
disease in human breast cancer patients, according to the researchers.
«We've seen hints before that PAK4 and PI3K pathway are linked, but finding evidence of their interaction is an important advance because it gives us
additional avenues to explore
in testing promising new inhibitor compounds that can tackle this
disease,» says Dr Claire Wells, who led the study.
«This drug was not developed as an alternative to vaccination but rather as an
additional weapon
in our arsenal against the virus that may enable us to improve
disease management and rapidly silence outbreaks,» he says.
These
additional genetic elements, however, are already
in use for screening and testing for
diseases such as breast cancer, prostate cancer and autoimmune
diseases, Richard Myers, president of HudsonAlpha Institute for Biotechnology
in Ala., noted
in the briefing.
The researchers plan to test
additional potential targets
in hopes that these particles could eventually be deployed to treat cancer, atherosclerosis, and other
diseases.
But
in many cases, unless there are
additional spillover events, the
disease eventually fades out.
The mean age of the K: B fusion population was 7.4 years old, compared to 15.2 years old
in the non-K: B population; 73 percent of the K: B PAs were found
in the cerebellum, whereas 78 percent of the non-K: B PAs were found elsewhere; and non-K: B PAs were much more likely associated with co-occurrence of the
disease Type 1 Neurofibromatosis, which can lead to the formation of
additional tumors.
Interestingly, IBS biologists uncovered
additional miRNA end modifications after DROSHA processing, which are expected to be important for the regulation of miRNA biogenesis, whose dysregulation is often associated with
diseases,
in particular with cancer.
While this study indicates that the economic and
disease burdens of dengue
in India are hundreds of times greater than estimates based entirely on official reports, further studies are needed to garner
additional detail.